TipRanks
Go Ultimate55% OFF

Merit Medical Systems (MM3) Stock Statistics & Valuation Metrics

Total Valuation

Merit Medical Systems has a market cap or net worth of EUR 4.61B. The enterprise value is EUR 5.52B.

Market Cap
EUR 4.61B
Enterprise Value
EUR 5.52B

Share Statistics

Merit Medical Systems has 59,915,043 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
59,915,043
Owned by Insiders
2.65%
Owned by Institutions
72.38%

Financial Efficiency

Merit Medical Systems’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 5.64%.

Return on Equity (ROE)
0.08
Return on Assets (ROA)
0.05
Return on Invested Capital (ROIC)
5.64%
Return on Capital Employed (ROCE)
0.08
Revenue Per Employee
201.96K
Profits Per Employee
17.13K
Employee Count
7,500
Asset Turnover
0.56
Inventory Turnover
2.33

Valuation Ratios

The current PE Ratio of Merit Medical Systems is 32.06. Merit Medical Systems’s PEG ratio is 0.95.

PE Ratio
32.06
PS Ratio
3.20
PB Ratio
2.96
Price to FCF
25.21
Price to Operating Cash Flow
18.84
PEG Ratio
0.95

Income Statement

In the last 12 months, Merit Medical Systems had revenue of 1.51B and earned 128.49M in profits. Earnings per share was 2.17.

Revenue
1.51B
Gross Profit
736.94M
Operating Income
184.38M
Pretax Income
170.94M
Net Income
128.49M
EBITDA
332.05M
Earnings Per Share (EPS)
2.17

Cash Flow

In the last 12 months, operating cash flow was 273.74M and capital expenditures -69.50M, giving a free cash flow of 204.24M billion.

Operating Cash Flow
273.74M
Free Cash Flow
204.24M
Free Cash Flow per Share
3.42

Dividends & Yields

Merit Medical Systems pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
3.95%
Earnings Yield
3.10%

Stock Price Statistics

Beta
0.40
52-Week Price Change
10.81%
50-Day Moving Average
77.20
200-Day Moving Average
65.75
Relative Strength Index (RSI)
61.17
Average Volume (3m)
50

Important Dates

Merit Medical Systems upcoming earnings date is Feb 24, 2027, TBA (Not Confirmed).

Last Earnings Date
Oct 29, 2026
Next Earnings Date
Feb 24, 2027
Ex-Dividend Date
―

Financial Position

Merit Medical Systems as a current ratio of 4.34, with Debt / Equity ratio of 56.70%

Current Ratio
4.34
Quick Ratio
2.95
Debt to Market Cap
0.16
Net Debt to EBITDA
1.35
Interest Coverage Ratio
6.97

Taxes

In the past 12 months, Merit Medical Systems has paid 42.45M in taxes.

Income Tax
42.45M
Effective Tax Rate
0.25

Enterprise Valuation

Merit Medical Systems EV to EBITDA ratio is 14.53, with an EV/FCF ratio of 26.86.

EV to Sales
3.40
EV to EBITDA
14.53
EV to Free Cash Flow
26.86
EV to Operating Cash Flow
20.04

Balance Sheet

Merit Medical Systems has EUR 503.55M in cash and marketable securities with EUR 822.06M in debt, giving a net cash position of -EUR 318.51M billion.

Cash & Marketable Securities
EUR 503.55M
Total Debt
EUR 822.06M
Net Cash
-EUR 318.51M
Net Cash Per Share
-EUR 5.32
Tangible Book Value Per Share
EUR 10.30

Margins

Gross margin is 49.41%, with operating margin of 13.49%, and net profit margin of 9.94%.

Gross Margin
49.41%
Operating Margin
13.49%
Pretax Margin
13.14%
Net Profit Margin
9.94%
EBITDA Margin
23.43%
EBIT Margin
15.15%

Analyst Forecast

The average price target for Merit Medical Systems is EUR 95.19, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
EUR 95.19
Price Target Upside
16.09% Upside
Analyst Consensus
Strong Buy
Analyst Count
9
Revenue Growth Forecast
4.03%
EPS Growth Forecast
27.04%

Scores

Smart Score
9
AI Score
―